Page last updated: 2024-08-22

dideoxyadenosine and HIV Coinfection

dideoxyadenosine has been researched along with HIV Coinfection in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (77.78)	18.2507
2000's	1 (11.11)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Jesson, J; Leroy, V; O'Rourke, J; Penazzato, M; Renaud, F; Revegue, MHDT; Saint-Lary, L; Townsend, CL	1
Azzam, R; Chan, H; Crowe, SM; Cunningham, AL; Doischer, D; Gorry, PR; Jaworowski, A; Kedzierska, K; Leeansyah, E	1
Adelsberger, J; Baseler, M; Boyle, MJ; Connors, M; Davey, RT; Flanigan, ME; Ford, H; Geiger, SP; Lane, HC	1
Fahey, JL; Hofmann, B; Liu, M; Nguyen, T; Nishanian, P	1
Boone, E; Davey, RT; Driscoll, JS; Ford, H; Lane, HC; Ruxrungtham, K	1
Cadman, J	1
Hanna, L	1
Cao, W; Fuchs, BA; Germolec, DR; Luster, MI; Munson, AE; Prejean, JD; Rosenthal, GJ; Shopp, G; Thompson, MB; Tomaszewski, JE	1

Reviews

1 review(s) available for dideoxyadenosine and HIV Coinfection

Article	Year
Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis. The Lancet. Child & adolescent health, 2022, Volume: 6, Issue:10 Topics: Adolescent; Adult; Anti-HIV Agents; Child; Cross-Sectional Studies; Cyclopropanes; Dideoxyadenosine; HIV Infections; Humans; Infant; Nucleosides; Observational Studies as Topic; Prospective Studies; Retrospective Studies; Reverse Transcriptase Inhibitors	2022

Article

Year

Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis.

The Lancet. Child & adolescent health, 2022, Volume: 6, Issue:10

Topics: Adolescent; Adult; Anti-HIV Agents; Child; Cross-Sectional Studies; Cyclopropanes; Dideoxyadenosine; HIV Infections; Humans; Infant; Nucleosides; Observational Studies as Topic; Prospective Studies; Retrospective Studies; Reverse Transcriptase Inhibitors

2022

Other Studies

8 other study(ies) available for dideoxyadenosine and HIV Coinfection

Article	Year
Impaired complement-mediated phagocytosis by HIV type-1-infected human monocyte-derived macrophages involves a cAMP-dependent mechanism. AIDS research and human retroviruses, 2006, Volume: 22, Issue:7 Topics: Animals; Cyclic AMP; Dideoxyadenosine; Dinoprostone; Erythrocytes; Flow Cytometry; HIV Infections; HIV-1; Humans; Imines; Macrophages; Phagocytosis; Receptors, Complement; Sheep; Virus Replication	2006
The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy. Journal of immunology (Baltimore, Md. : 1950), 1995, Jun-15, Volume: 154, Issue:12 Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antiviral Agents; Base Sequence; CD4-Positive T-Lymphocytes; Dideoxyadenosine; Disease Models, Animal; DNA Primers; DNA, Viral; Genes, env; HIV Infections; HIV-1; Humans; Immunotherapy, Adoptive; Lymphocyte Count; Lymphocyte Transfusion; Male; Mice; Mice, SCID; Molecular Sequence Data; Proviruses; Transplantation, Heterologous; Tumor Necrosis Factor-alpha; Viremia	1995
Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS (London, England), 1993, Volume: 7, Issue:5 Topics: Adenosine; Amino Acid Sequence; Antigens, Fungal; Candida albicans; Cyclic AMP; Dideoxyadenosine; HIV Infections; Humans; In Vitro Techniques; Intracellular Fluid; Lymphocyte Activation; Molecular Sequence Data; Oligopeptides; Protein Kinases; Substrate Specificity; T-Lymphocytes	1993
Potent activity of 2'-beta-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10 Topics: Animals; Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxyadenosine; DNA, Viral; Female; Flow Cytometry; Half-Life; HIV Infections; HIV-1; Humans; Immunochemistry; Immunoglobulin G; Mice; Mice, SCID; Polymerase Chain Reaction	1996
F-ddA for HIV. Treatment review, 1996, Issue:No 22 Topics: Antiviral Agents; Dideoxyadenosine; HIV Infections; Humans	1996
Looking down the drug pipeline. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1998, Volume: 12, Issue:3 Topics: Adenine; Animals; Anti-HIV Agents; Biological Availability; Chlorobenzenes; Clinical Trials as Topic; Codon; Dideoxyadenosine; Drug Resistance, Microbial; Drugs, Investigational; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Infections; HIV Protease Inhibitors; Humans; Naphthalenes; Organophosphonates; Pyrimidinones; Receptors, CCR5; Receptors, CXCR4; Reverse Transcriptase Inhibitors; Tenofovir	1998
FddA: antiretroviral in development. BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1998 Topics: Anti-HIV Agents; Clinical Trials, Phase I as Topic; Dideoxyadenosine; Drug Stability; Drugs, Investigational; HIV Infections; Humans	1998
Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection. International journal of immunopharmacology, 1991, Volume: 13 Suppl 1 Topics: Animals; Bone Marrow; Didanosine; Dideoxyadenosine; Female; HIV Infections; Immune System; Immunoglobulin M; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Zalcitabine; Zidovudine	1991